SOX4 and colorectal carcinoma: Previous studies suggested that FENDRR attenuated CRC progression by repressing SOX4 and that FENDRR levels are negatively correlated with advanced stage and poor clinical outcomes (31); thus, overexpression of FENDRR suppresses the proliferation, migration, and invasion of CRC cells.